Leflunomide Induces Dose-Dependent Lung Injury in Mice via Stimulating Vimentin and NLRP3 Inflammasome Production

Recently, the therapeutic importance of the anti-rheumatic drug, leflunomide, has been increased after the involvement of leflunomide in treating other autoimmune diseases and its promising role in retarding human malignancies. Few studies have focused on the safety in human or animals without clear...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Principais autores: El-Sherbiny, Mohamed, Atef, Hoda, Eladl, Mohamed Ahmed, Mohamed, Abdelaty Shawky, El-Shafey, Mohamed, Ali, Howaida S., Zaitone, Sawsan A., Alomar, Suliman Y., Alqahtani, Saeed Awad M., Aloyouni, Sheka Yagub, Attia, Mohammed A.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8115235/
https://ncbi.nlm.nih.gov/pubmed/33995030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.631216
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados